BCR and acute lymphoblastic leukemia: Unlike VpreB, CD79b harbors an ITAM in the cytoplasmic domain by which CD79b on the cell surface may promote downstream signaling, irrespective of a fully arranged pre-BCR complex, thereby enhancing the survival and proliferation of BCP-ALL cells.